These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21673276)

  • 1. Proteomic analysis and discovery using affinity proteomics and mass spectrometry.
    Olsson N; Wingren C; Mattsson M; James P; O'Connell D; Nilsson F; Cahill DJ; Borrebaeck CA
    Mol Cell Proteomics; 2011 Oct; 10(10):M110.003962. PubMed ID: 21673276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategy for surveying the proteome using affinity proteomics and mass spectrometry.
    Wingren C; James P; Borrebaeck CA
    Proteomics; 2009 Mar; 9(6):1511-7. PubMed ID: 19235165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative proteomics targeting classes of motif-containing peptides using immunoaffinity-based mass spectrometry.
    Olsson N; James P; Borrebaeck CA; Wingren C
    Mol Cell Proteomics; 2012 Aug; 11(8):342-54. PubMed ID: 22543061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affinity proteomics: the role of specific binding reagents in human proteome analysis.
    Stoevesandt O; Taussig MJ
    Expert Rev Proteomics; 2012 Aug; 9(4):401-14. PubMed ID: 22967077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of short terminal motifs enriched by antibodies using peptide mass fingerprinting.
    Planatscher H; Weiß F; Eisen D; van den Berg BH; Zell A; Joos T; Poetz O
    Bioinformatics; 2014 May; 30(9):1205-13. PubMed ID: 24413521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of high-density antibody microarrays for disease proteomics: key technological issues.
    Borrebaeck CA; Wingren C
    J Proteomics; 2009 Aug; 72(6):928-35. PubMed ID: 19457338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advancing the global proteome survey platform by using an oriented single chain antibody fragment immobilization approach.
    Säll A; Persson H; Ohlin M; Borrebaeck CA; Wingren C
    N Biotechnol; 2016 Sep; 33(5 Pt A):503-13. PubMed ID: 26703809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic antibody and antigen-based proteomic profiling with microarrays.
    Ayoglu B; Häggmark A; Neiman M; Igel U; Uhlén M; Schwenk JM; Nilsson P
    Expert Rev Mol Diagn; 2011 Mar; 11(2):219-34. PubMed ID: 21405972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
    Smith JG; Gerszten RE
    Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High throughput and accurate serum proteome profiling by integrated sample preparation technology and single-run data independent mass spectrometry analysis.
    Lin L; Zheng J; Yu Q; Chen W; Xing J; Chen C; Tian R
    J Proteomics; 2018 Mar; 174():9-16. PubMed ID: 29278786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broad-based proteomic strategies: a practical guide to proteomics and functional screening.
    Graham DR; Elliott ST; Van Eyk JE
    J Physiol; 2005 Feb; 563(Pt 1):1-9. PubMed ID: 15611015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AFFIRM--a multiplexed immunoaffinity platform that combines recombinant antibody fragments and LC-SRM analysis.
    Säll A; Carlsson F; Olsson N; Wingren C; Ohlin M; Persson H; Waldemarson S
    J Proteome Res; 2014 Dec; 13(12):5837-47. PubMed ID: 25337893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond antibodies: new affinity reagents to unlock the proteome.
    Lollo B; Steele F; Gold L
    Proteomics; 2014 Mar; 14(6):638-44. PubMed ID: 24395722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of the difference in proteome expression between yeast form and mould form of Penicillium marneffei using SELDI technique].
    Liu DH; Liu XJ; Tan SS
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jan; 27(1):59-61. PubMed ID: 17259147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis of human plasma proteins by two-dimensional gel electrophoresis and by antibody arrays following depletion of high-abundance proteins.
    Desrosiers RR; Beaulieu E; Buchanan M; Béliveau R
    Cell Biochem Biophys; 2007; 49(3):182-95. PubMed ID: 17952643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tandem affinity depletion: a combination of affinity fractionation and immunoaffinity depletion allows the detection of low-abundance components in the complex proteomes of body fluids.
    Mortezai N; Harder S; Schnabel C; Moors E; Gauly M; Schlüter H; Wagener C; Buck F
    J Proteome Res; 2010 Dec; 9(12):6126-34. PubMed ID: 20839810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and analyses of human synthetic antibody libraries and their application for protein microarrays.
    Säll A; Walle M; Wingren C; Müller S; Nyman T; Vala A; Ohlin M; Borrebaeck CAK; Persson H
    Protein Eng Des Sel; 2016 Oct; 29(10):427-437. PubMed ID: 27590051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC)-Based Quantitative Proteomics and Phosphoproteomics in Fission Yeast.
    Carpy A; Koch A; Bicho CC; Borek WE; Hauf S; Sawin KE; Maček B
    Cold Spring Harb Protoc; 2017 Jun; 2017(6):pdb.prot091686. PubMed ID: 28572185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput proteomics using antibody microarrays.
    Wingren C; Borrebaeck CA
    Expert Rev Proteomics; 2004 Oct; 1(3):355-64. PubMed ID: 15966831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein microarray-based screening of antibody specificity.
    Bangham R; Michaud GA; Schweitzer B; Predki PF
    Methods Mol Med; 2005; 114():173-82. PubMed ID: 16156103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.